Eli Lilly reduces the price of its obesity medication, Zepbound®, offering discounted single-dose vials to expand access for self-pay patients with an on-label prescription. Learn more about this cost-cutting initiative.

Explore the impact of Oprah Winfrey's candid admission about using weight loss medications. Ozempic and Wegovy continue to gain popularity. Dive into the growing trend of GLP-1 agonists for weight management and what this means for public perception and industry practices.